Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2021

01-06-2021 | Obesity | Research article

RETRACTED ARTICLE: Luffa cylindrica: a promising herbal treatment in progesterone induced obesity in mice

Authors: Wilnoska Wilnellia D’silva, Prakash Rajshekhar Biradar, Ashwini Patil

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2021

Login to get access

Abstract

Objective

The present study investigates the anti-obesity activity of Luffa cylindrica in progesterone induced obesity model.

Method

Swiss albino mice were grouped into 7 (n = 6). Obesity was induced by administration of progesterone (10 mg/kg s.c.) for 28 days. Normal group received ad libitum and water. Disease control, positive control and treatment groups received progesterone (10 mg/kg s.c.). Further positive control group received Orlistat (10 mg/kg p.o). Treatment groups received hydro-alcoholic and fractionation extract of Luffa cylindrica at doses 400, 200, 100 mg/kg b.w. Food and water intake were recorded daily, Body weight, BMI and blood glucose were checked weekly. On completion of the study, animals were sacrificed and blood serum being utilized to accesses in vitro to estimate the various biochemical parameters. Serotonin levels and antioxidant biomarkers were also estimated. Histopathology of liver and adipose tissue was studied.

Result

After the 28 days of treatment with plant extract and fraction, it was observed to improve the progestrogen-induced obesity by improving BMI, body weight, brain serotionin, locomotor activity, blood glucose level, anti-oxidant biomarkers, and lipid profile.

Conclusion

After assimilating the In vivo and in vitro studies Luffa cylindrical extract highlighted the antilipidemic, anti-hyperglycaemic, antioxidant potential in hormone-induced obesity.
Literature
1.
go back to reference Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595–600.CrossRefPubMed Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595–600.CrossRefPubMed
2.
go back to reference Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–54.CrossRefPubMed Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–54.CrossRefPubMed
3.
go back to reference Piché M-E, Poirier P, Lemieux I, Després J-P. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis. 2018;61:103–13.CrossRefPubMed Piché M-E, Poirier P, Lemieux I, Després J-P. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis. 2018;61:103–13.CrossRefPubMed
4.
go back to reference Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980 2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766–81.CrossRefPubMedPubMedCentral Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980 2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766–81.CrossRefPubMedPubMedCentral
5.
go back to reference Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. Int J Epidemiol. 2014;43(3):655–65.CrossRefPubMed Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. Int J Epidemiol. 2014;43(3):655–65.CrossRefPubMed
6.
go back to reference Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation. 2009;120(1):86–95.CrossRefPubMed Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation. 2009;120(1):86–95.CrossRefPubMed
7.
go back to reference Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity Committee of the Council on nutrition, physical activity, and metabolism. Circulation. 2006;113(6):898–918.CrossRefPubMed Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity Committee of the Council on nutrition, physical activity, and metabolism. Circulation. 2006;113(6):898–918.CrossRefPubMed
8.
go back to reference Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Emerging Risk Factors collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–95.CrossRefPubMed Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Emerging Risk Factors collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–95.CrossRefPubMed
9.
go back to reference Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56(4):369–81.CrossRefPubMed Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56(4):369–81.CrossRefPubMed
10.
go back to reference Asarian L, Geary N. Modulation of appetite by gonadal steroid hormones. Philos Trans R Soc Lond Ser B Biol Sci. 2006;361(1471):1251–63.CrossRef Asarian L, Geary N. Modulation of appetite by gonadal steroid hormones. Philos Trans R Soc Lond Ser B Biol Sci. 2006;361(1471):1251–63.CrossRef
11.
go back to reference Carlson MJ, Thiel KW, Yang S, Leslie KK. Catch It Before It Kills: Progesterone, Obesity, and the Prevention of Endometrial Cancer. Discov Med. 2012;14(76):215–22 PMCID: PMC3964851.PubMedPubMedCentral Carlson MJ, Thiel KW, Yang S, Leslie KK. Catch It Before It Kills: Progesterone, Obesity, and the Prevention of Endometrial Cancer. Discov Med. 2012;14(76):215–22 PMCID: PMC3964851.PubMedPubMedCentral
12.
go back to reference Amatayakul K, Sivasomboon B, Thanangkul O. A study of the mechanism of weight gain in medroxyprogesterone acetate users. Contraception. 1980;22(6):605–22.CrossRefPubMed Amatayakul K, Sivasomboon B, Thanangkul O. A study of the mechanism of weight gain in medroxyprogesterone acetate users. Contraception. 1980;22(6):605–22.CrossRefPubMed
13.
go back to reference Wallace JM, Shively CA, Clarkson TB. Effects of hormone replacement therapy and social stress on body fat distribution surgically postmenopausal monkeys. Int J Obes. 1999;23:518–27.CrossRef Wallace JM, Shively CA, Clarkson TB. Effects of hormone replacement therapy and social stress on body fat distribution surgically postmenopausal monkeys. Int J Obes. 1999;23:518–27.CrossRef
14.
go back to reference Bäckström T. Symptoms related to the menopause and sex steroid treatments. CIBA Found Symp. 1995;191:171–80 discussion 180-6.PubMed Bäckström T. Symptoms related to the menopause and sex steroid treatments. CIBA Found Symp. 1995;191:171–80 discussion 180-6.PubMed
15.
go back to reference Crammer JL. Premenstrual depression, cortisol and oestradiol treatment. Psychol Med. 1986;16(2):451–5.CrossRefPubMed Crammer JL. Premenstrual depression, cortisol and oestradiol treatment. Psychol Med. 1986;16(2):451–5.CrossRefPubMed
16.
go back to reference Bethea CL, Gundlah C, Mirkes SJ. Ovarian steroid action in the serotonin neural system of macaques. Novartis Found Symp. 2000;230:112–30.PubMed Bethea CL, Gundlah C, Mirkes SJ. Ovarian steroid action in the serotonin neural system of macaques. Novartis Found Symp. 2000;230:112–30.PubMed
17.
go back to reference Kaur G, Kulkarni SK. Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice. Brain Res. 2002;943(2):206–15.CrossRefPubMed Kaur G, Kulkarni SK. Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice. Brain Res. 2002;943(2):206–15.CrossRefPubMed
18.
go back to reference WHO. Obesity: preventing and managing the global epidemic. WHO Technical Report Series number 894. Geneva: WHO; 2000. WHO. Obesity: preventing and managing the global epidemic. WHO Technical Report Series number 894. Geneva: WHO; 2000.
19.
go back to reference Lee YS, Cha BY, Saito K, Choi SS, Wang XX, Choi BK, et al. Effects of a Citrus depressa Hayata (shiikuwasa) extract on obesity in high-fat diet- induced obese mice. Phytomedicine. 2011;18(8–9):648–54.CrossRefPubMed Lee YS, Cha BY, Saito K, Choi SS, Wang XX, Choi BK, et al. Effects of a Citrus depressa Hayata (shiikuwasa) extract on obesity in high-fat diet- induced obese mice. Phytomedicine. 2011;18(8–9):648–54.CrossRefPubMed
20.
go back to reference Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, et al. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP- 1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab. 2011;300(1):E122–33.CrossRefPubMed Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, et al. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP- 1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab. 2011;300(1):E122–33.CrossRefPubMed
22.
go back to reference AZEEZ MA, BELLO OS, Omobola A. Traditional and medicinal uses of Luffa cylindrica :a Review. J Med Plants Studies. 2013;1(5):102–11. AZEEZ MA, BELLO OS, Omobola A. Traditional and medicinal uses of Luffa cylindrica :a Review. J Med Plants Studies. 2013;1(5):102–11.
23.
go back to reference Partap S, Kumar A, Sharma NK, Jha KK. Luffa Cylindrica: An important medicinal plant. J Nat Prod Plant Resour. 2012;2(1):127–34. Partap S, Kumar A, Sharma NK, Jha KK. Luffa Cylindrica: An important medicinal plant. J Nat Prod Plant Resour. 2012;2(1):127–34.
24.
go back to reference Khare CP. Indian medicinal plants: an illustrated dictionary. Springer Science & Business Media; 2008. Khare CP. Indian medicinal plants: an illustrated dictionary. Springer Science & Business Media; 2008.
26.
go back to reference Nderitu KW, Mwenda NS, Macharia NJ, Barasa SS, Ngugi MP. Antiobesity activities of Methanolic extracts of Amaranthus dubius, Cucurbita pepo, and Vigna unguiculata in progesterone-induced obese mice. Evid Based Complement Alternat Med. 2017;2017:4317321.CrossRefPubMedPubMedCentral Nderitu KW, Mwenda NS, Macharia NJ, Barasa SS, Ngugi MP. Antiobesity activities of Methanolic extracts of Amaranthus dubius, Cucurbita pepo, and Vigna unguiculata in progesterone-induced obese mice. Evid Based Complement Alternat Med. 2017;2017:4317321.CrossRefPubMedPubMedCentral
28.
go back to reference Schlumpf M, Lichtensteiger W, Langemann H, Waser PG, Hefti F. A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue. Biochem Pharmacol. 1974;23(17):2437–46.CrossRefPubMed Schlumpf M, Lichtensteiger W, Langemann H, Waser PG, Hefti F. A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue. Biochem Pharmacol. 1974;23(17):2437–46.CrossRefPubMed
29.
go back to reference Clark MK, Dillon JS, Sowers M, Nichols S. Weight, fat mass, and central distribution of fat increase when women use depot medroxyprogesterone acetate for contraception. Int J Obesity. 2005;29:1252–8.CrossRef Clark MK, Dillon JS, Sowers M, Nichols S. Weight, fat mass, and central distribution of fat increase when women use depot medroxyprogesterone acetate for contraception. Int J Obesity. 2005;29:1252–8.CrossRef
30.
go back to reference Shirling D, Ashby JP, Baird JD. Effect of progesterone on lipid metabolism in the intact rat. J Endocrinol. 1981;90(2):285–94.CrossRefPubMed Shirling D, Ashby JP, Baird JD. Effect of progesterone on lipid metabolism in the intact rat. J Endocrinol. 1981;90(2):285–94.CrossRefPubMed
36.
go back to reference Duyu T, Khanal P, Khatib NA, Patil BM. Mimosa pudica modulates Neuroactive ligand-receptor interaction in Parkinson’s disease. Indian J Pharm Educ Res. 2020;54(3):732–9.CrossRef Duyu T, Khanal P, Khatib NA, Patil BM. Mimosa pudica modulates Neuroactive ligand-receptor interaction in Parkinson’s disease. Indian J Pharm Educ Res. 2020;54(3):732–9.CrossRef
37.
go back to reference Khanal P, Patil BM. In vitro and in silico anti-oxidant, cytotoxicity and biological activities of Ficus benghalensis and Duranta repens. Chinese Herbal Med. 2020;12(4):406–13.CrossRef Khanal P, Patil BM. In vitro and in silico anti-oxidant, cytotoxicity and biological activities of Ficus benghalensis and Duranta repens. Chinese Herbal Med. 2020;12(4):406–13.CrossRef
Metadata
Title
RETRACTED ARTICLE: Luffa cylindrica: a promising herbal treatment in progesterone induced obesity in mice
Authors
Wilnoska Wilnellia D’silva
Prakash Rajshekhar Biradar
Ashwini Patil
Publication date
01-06-2021
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2021
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-021-00749-8

Other articles of this Issue 1/2021

Journal of Diabetes & Metabolic Disorders 1/2021 Go to the issue